Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Mar 24, 2023

BUY
$4.39 - $5.66 $8,780 - $11,320
2,000 New
2,000 $12.1 Million
Q1 2019

Mar 24, 2023

BUY
$3.19 - $5.73 $6,380 - $11,460
2,000 New
2,000 $13.9 Million
Q4 2018

Mar 24, 2023

SELL
$2.95 - $4.15 $19,995 - $28,128
-6,778 Closed
0 $0
Q3 2018

Mar 24, 2023

BUY
$3.91 - $4.66 $26,501 - $31,585
6,778 New
6,778 $36.1 Million
Q1 2018

Mar 24, 2023

BUY
$6.24 - $9.15 $42,294 - $62,018
6,778 New
6,778 $54.6 Million
Q4 2017

Mar 24, 2023

BUY
$7.99 - $11.87 $37,664 - $55,955
4,714
4,714 $48.3 Million

Others Institutions Holding MACK

About MERRIMACK PHARMACEUTICALS INC


  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.